SXTPW

60 Degrees Pharm

• Dow Jones·1d ago

  60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

• Seeking Alpha·04/03 12:20

  Most and least shorted healthcare stocks with up to $2B market cap in March

• Reuters·04/02 13:04

  60 Degrees Pharma CEO touts tafenoquine expansion push into babesiosis in Bloomberg TV interview

• TipRanks·03/31 14:20

  Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)

• Seeking Alpha·03/31 13:34

  60 Degrees Pharmaceuticals GAAP EPS of -$11.73 misses by $4.83, revenue of $1M misses by $1.05M

• Benzinga·03/31 11:50

  60 Degrees Q4 EPS $(1.47) Misses $(1.12) Estimate, Sales $303.385K Miss $400.000K Estimate

• Dow Jones·03/31 11:08

  *60 Degrees Pharm 2025 Net Product Rev $1M Vs. $607,600 >SXTP

• Dow Jones·03/31 11:01

  Press Release: 60 Degrees Pharmaceuticals Announces 2025 Annual Results

• Reuters·03/30 21:32

  60 Degrees Pharma FY25 operating loss narrows 16.24% to $8.4 million

• Benzinga·03/24 21:05

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• TipRanks·03/20 20:59

  60 Degrees Updates Affiliate Share Ownership Disclosure Error

• Reuters·03/20 20:15

  60 Degrees Pharmaceuticals corrects affiliate beneficial ownership to 23,367 shares

• Reuters·03/18 12:38

  60 Degrees Pharmaceuticals files NDIN with FDA for Australian Chestnut Extract

• TipRanks·03/18 12:12

  60 Degrees submits NDIN to FDA for Australian Chestnut Extract

• Benzinga·03/18 12:10

  60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification With FDA For Australian Chestnut Extract; Inks Deal To License Florida State University's Ownership Rights To New Capsule Formulation Methods For Australian Chestnut Extract